Living meta-analysis and evidence synthesis of therapies for COVID-19

click on circles to display study description...

Ghandehari, 2020 NCT04365127

progesterone (n=20) vs. standard of care (n=22)

randomized controlled trial   some concerns about risk of bias

Studied treatment

subcutaneous progesterone
progesterone (100 mg subcutaneously twice daily for up to 5 days) plus SOC

Control treatment

SOC alone

Patients

COVID-19 mild to moderate

Method

open-label

Cedars Sinai Medical Center, Los Angeles, USA

Remark